Medgold to Acquire Klondike Gold's Portuguese Assets and Arranges
$1.5 Million Financing
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec 11, 2013) -
Medgold Resources Corp. (TSX-VENTURE:MED), the European focused
gold exploration company, is pleased to announce that it has signed
a Letter of Intent ("LOI") with Klondike Gold Corp ("Klondike") for
the acquisition of 100% of its Portuguese assets which comprise
five gold exploration permits covering 600 sq km in northern
Portugal, primarily located along the Valongo Belt. The Company is
also conducting a $1.5 million non-brokered private placement to
primarily fund exploration activity. Both the acquisition and
private placement are subject to TSX Venture Exchange approval.
Highlights
- Four of five acquired exploration licences are located along
the Valongo Belt - a major gold-bearing district.
- Near-surface gold mineralization previously delineated at
Castromil within the Legares licence area:
- Historical mineral resource estimate of 2.42Mt at 1.89g/t Au
for approximately 145,000 oz Au. A qualified person has not
done sufficient work to classify the historical estimate as a
current mineral resource, and the Company is not treating the
historical resource as current. See below for a discussion of the
historical estimate.
- Strong potential to significantly increase known mineralization
following recent work by Company's consultant demonstrating that
the mineralization described in the historical resource estimate is
open at depth and along strike in both directions.
- The fifth licence, Ponte de Barca, shares similar geology and
mineralization style to the Company's Boticas gold project, where
Medgold has identified broad areas (20 to 40 metres) grading 2 to 4
g/t Au hosted by sheeted veins.
- Acquisition is in line with strategy to secure and develop a
portfolio of highly prospective gold projects focused on western
Europe.
- Financing being arranged for $1.5 million.
Dan James, the President of Medgold, said, "By significantly
increasing our exploration portfolio, this acquisition underpins
our objective to become a leading gold explorer and developer in
Western Europe. Our land-holding in Portugal now covers over 1,000
sq km of highly prospective ground, and hosts numerous areas of
gold mineralization, such as the Valongo Belt. Recent
reinterpretation of the structural setting and geological controls
on mineralization within the Valongo Belt, by geological consultant
and Company adviser, Jim Mortensen, has led to significant
upgrading of the exploration potential of the region. With the
funds raised we look forward to continuing this work in the New
Year, strategically advancing these projects along the development
curve, as we look to delineate and prove-up economic zones of gold
mineralization. This acquisition allows Medgold to advance
significantly in building a first-class exploration portfolio and
generating significant shareholder value through successful
exploration and development."
The Klondike Projects
The Klondike projects combine five exploration licences
(Balazar, Valongo, Legares, Castelo do Paiva and Ponte de Barca),
totaling 604 sq km, with four covering the majority of the Valongo
anticline, plus Ponte de Barca, which covers several orogenic gold
occurrences in the very north of Portugal. The Valongo anticline is
a large overturned fold hosting numerous gold occurrences, many of
which were exploited by the Romans. Recent interpretations clearly
demonstrate that mineralization within the Valongo Belt was
introduced by a series of faults and fractures, and is focused into
'saddle reefs' and en echelon vein arrays, commonly with
zones of massive sulphide and quartz veining in a number of
different lithologies.
The most advanced project is the Castromil project, located
within the Legares licence. Historical exploration, undertaken by
both Connary Minerals plc ("Connary") and previous explorers,
focused on near-surface high-grade mineralization, and included
multiple phases of shallow percussion and diamond drilling,
culminating in a 1997 mineral resource estimate (historical, see
below) of 2.42 Mt at 1.89 g/t Au measured and indicated for
approximately 145,000 oz Au. ("Class III feasibility study,
Castrolmil Gold Mine, Portugal, for Connary Minerals plc", ACA
Howe Mining & Metallurgy Ltd., October 1997; "the Connary
Report"). Recent work by the Company's adviser, Jim Mortensen,
clearly demonstrates that the mineralization is open at depth and
along strike in both directions, highlighting the potential for
additional discovery.
A qualified person has not done sufficient work to classify
the historical mineral resource given in the Connary Report as a
current mineral resource, and the Company is not treating the
historical mineral resource as current. Neither the qualified
person nor the Company has independently verified the information
contained in the Connary Report. The historical mineral resource
was prepared by ACA Howe Mining & Metallurgy Ltd. using a
geologically constrained block model, with block grades calculated
using an anisotropic inverse distance weighting method with an
elliptical search radius oriented down the plunge of interpreted
mineralized rock volumes. The qualified person has been unable to
verify whether the definitions of "measured" and "indicated" used
in the Connary Report in the context of its mineral resource
statement are equivalent to those set out in section 1.2 of
National Instrument 43-101. The mineral resource statement in the
Connary Report does not report the measured and indicated resource
categories separately, and reports no resources in the inferred
category. The definition of "Class III feasibility study" described
in the Connary Report does not correspond to the definition of
"feasibility study" as set out in section 1.4 of National
Instrument 43-101. The work described in the Connary Report appears
to the Company and its qualified person to have been performed to a
high technical standard and they consider it reliable, but it is
currently unknown what work would be required to upgrade or verify
the historical mineral resource as current, or if it is
possible.
The Ponte de Barca licence is located in northern Portugal and
approximately 75 km northeast from the city of Porto. The geology
and controls on mineralization are very similar to the Boticas
project, where high-grade mineralization is controlled by a series
of strike-extensive and high-angle tension veins. Klondike has
completed some limited rock-chip sampling, with 15 samples
collected, yielding results from trace to 14.8, 12.9 and 12.0 g/t
Au. The Company has not independently verified Klondike's
results.
The Acquisition
The terms for the acquisition of Klondike's Portuguese assets
are as follows:
- Payment of $10,000 in cash upon signing of the LOI.
- Medgold will have up to 45 days to complete due diligence and
if satisfactory will make a payment of $40,000 in cash and $100,000
in Medgold shares, and complete the acquisition.
- A final payment in 12 months of $100,000 in cash and $250,000
in cash or shares (to be decided by Medgold).
- On closing of the purchase, Klondike will retain a 2.0% NSR,
which will be re-purchasable for $1.0 million per percentage
point.
Private Placement
The Company is also pleased to announce that it has arranged,
subject to TSX Venture Exchange approval, a non-brokered private
placement financing of up to 15 million units at $0.10 per unit,
for proceeds of up to $1.5 million. Each unit will consist of one
common share and one warrant entitling the holder to purchase one
additional common share of the Company at $0.15 for one year from
closing.
The Company may pay finder's fees on a portion of the financing,
payable in cash or units, plus finder's warrants which will be
exercisable into one common share of the Company at a price of
$0.15 for one year from closing.
The net proceeds of the placement will be used towards
exploration of the Company's properties in Europe and for general
working capital purposes.
Qualified Person
Mr. David Clark, M.Sc., P.Geo. (APEGBC), Consulting Geologist to
the Company, is a Qualified Person as defined by National
Instrument 43-101 - Standards of Disclosure for Mineral
Projects. Mr. Clark has approved the disclosure of technical
information contained in this news release.
About Medgold
Medgold is aiming to become the leading Mediterranean-focused
gold exploration and project development company, with an extensive
portfolio and pipeline of projects across Portugal, Italy and
Spain, targeting economically stressed, but politically stable
European countries that are seeking foreign investment to
invigorate the mining sector.
Additional information on Medgold can be found on the
Company's website at www.medgoldresources.com and by reviewing the
Company's page on SEDAR at www.sedar.com.
ON BEHALF OF THE BOARD
Daniel P. James, President & Director
Forward-looking statements
This press release may contain forward-looking statements
including, but not limited to, comments regarding the timing and
content of upcoming work programs, geological interpretations,
receipt of property titles, potential mineral recovery processes,
and other related matters. Forward-looking statements address
future events and conditions and therefore involve inherent risks
and uncertainties. Medgold's projects in Europe are at an early
stage and all estimates and projections are based on limited, and
possibly incomplete, data. More work is required before the
mineralization and the projects' economic aspects can be
confidently modelled. Actual results may differ materially from
those currently anticipated in this news release. No representation
or prediction is intended as to the results of future work, nor can
there be any promise that the estimates and projections herein will
be sustained in future work or that the projects will otherwise
prove to be economic.
Medgold Resources Corp. (Vancouver)Ralph RushtonInvestor
Relations+1 604-801-5432ralphr@goldgroup.comMedgold Resources Corp.
(UK and Portugal)Dan JamesPresident+44 (0) 7972
579188dj@medgoldresources.comwww.medgoldresources.com
Medgold Resources (TSXV:MED)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025
Medgold Resources (TSXV:MED)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025